Search - tctmd.com

Displaying 401 - 420 of 509

Sort: Relevancy | Date

Presentation TCT 2014

The Case for Medical Therapy without Revascularization in Most Patients with and without Diabetes

Presenter: George D. Dangas, Michael E. Farkouh, David J. Maron

September 16, 2014

Presentation TCT 2014

Case Introduction: A Diabetic Patient with Double Vessel Coronary Artery Disease How Should We Treat?

Presenter: George D. Dangas, Michael E. Farkouh, Manish A. Parikh

September 16, 2014

Presentation TCT 2014

Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT___

Presenter: Hiroyoshi Yokoi

September 16, 2014

Presentation TCT 2014

Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials

Presenter: Javaid Iqbal

September 16, 2014

Presentation TCT 2014

Percutaneous Coronary Intervention of Small Vessels in the RESOLUTE Global Clinical Program: The Impact of Diabetes Mellitus

Presenter: Milan Chag

September 16, 2014

Presentation TCT 2014

Case Presentation #1: The Diabetic Patient Needing Revascularization

Presenter: Alejandro Cherro, Liliana R. Grinfeld, Adolfo G López Campanher

September 13, 2014

Presentation TCT 2014

PCI Outcomes in Diabetic Patients Outside the United States and European Union

Presenter: Alejandro Cherro, Liliana R. Grinfeld, Alfredo E. Rodriguez

September 13, 2014

Presentation TCT 2014

Is There a Role for PCI in Revascularization of Diabetic Patients with Multivessel Disease?

Presenter: Roxana Mehran, Mohamed Sobhy, Habib Gamra

September 13, 2014

Presentation TCT 2014

PCI vs CABG: PCI for Most!

Presenter: Alejandro Cherro, Liliana R. Grinfeld, Gregg W. Stone

September 13, 2014

Presentation TCT 2014

PCI vs CABG: Surgery for Most!

Presenter: Alejandro Cherro, Liliana R. Grinfeld, Michael E. Farkouh

September 13, 2014

News Daily News

联合血运重建有望给糖尿病患者带来福音

L.A. McKeown

July 24, 2014

News Daily News

Hybrid Revascularization a Promising Option for Diabetic Patients

L.A. McKeown

July 24, 2014

Presentation

Clinical Outcomes of Hybrid Coronary Revascularization vs CABG in Patients with Diabetes

Presenter: R.E. Harskamp

July 18, 2014

News Daily News

Una Estrategia con Trimetazidina Reduce la NIC y la Lesión Miocárdica en Pacientes Diabéticos con ERC de Carácter entre Leve y Moderado

May 30, 2014

News Daily News

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

May 30, 2014

Presentation

Trimetazidine Impacts on Myocardial Injury and CIN in Diabetic Patients with RD Undergoing Elective PCI

Presenter: Mohamed A. Shehata

May 27, 2014

News Daily News

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

L.A. McKeown

April 11, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

Presentation

Effect of Aleglitazar on Cardiovascular Outcomes after ACS in Patients with Type 2 Diabetes

Presenter: A. Michael Lincoff

April 04, 2014

Presentation PCI Outcomes 2014

Perspectives on PCI vs CABG in the Diabetic Patient: The FREEDOM to Disagree with FREEDOM

Presenter: Gregg W. Stone

March 28, 2014

Advertisement

The Case for Medical Therapy without Revascularization in Most Patients with and without Diabetes

Case Introduction: A Diabetic Patient with Double Vessel Coronary Artery Disease How Should We Treat?

Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT___

Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials

Percutaneous Coronary Intervention of Small Vessels in the RESOLUTE Global Clinical Program: The Impact of Diabetes Mellitus

Case Presentation #1: The Diabetic Patient Needing Revascularization

PCI Outcomes in Diabetic Patients Outside the United States and European Union

Is There a Role for PCI in Revascularization of Diabetic Patients with Multivessel Disease?

PCI vs CABG: PCI for Most!

PCI vs CABG: Surgery for Most!

联合血运重建有望给糖尿病患者带来福音

Hybrid Revascularization a Promising Option for Diabetic Patients

Clinical Outcomes of Hybrid Coronary Revascularization vs CABG in Patients with Diabetes

Una Estrategia con Trimetazidina Reduce la NIC y la Lesión Miocárdica en Pacientes Diabéticos con ERC de Carácter entre Leve y Moderado

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

Trimetazidine Impacts on Myocardial Injury and CIN in Diabetic Patients with RD Undergoing Elective PCI

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Effect of Aleglitazar on Cardiovascular Outcomes after ACS in Patients with Type 2 Diabetes

Perspectives on PCI vs CABG in the Diabetic Patient: The FREEDOM to Disagree with FREEDOM

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content